Blog

  • Prostate cancer and nutrition: What every Kenyan man should know.

    Prostate cancer and nutrition: What every Kenyan man should know.

    Prostate cancer is the most common cancer among men in Kenya. It accounts for approximately 14.4% of all male cancer cases. Yet, it is not talked about enough. Our latest data show 2800 new cases and 1300 deaths every year, with most detected late. This limits treatment options, and the outcome is mostly poor. While screening is the gold standard for early detection, research indicates that nutrition plays a vital role in reducing risks and enhancing long-term health. Food is information for your cells, not just fuel. In Kenya, where cultural preferences like nyama choma, fried foods, and alcohol are high, diet can be a quiet enabler of cancer risk.

     Building a prostate-friendly Kenyan plate

    1. Tomatoes and Red Fruits

    Cooked tomatoes, guavas, and watermelon are rich in lycopene. It is a powerful antioxidant associated with a lower risk of prostate cancer. Add blended tomato sauces to ugali and sukuma instead of just onions and oil.

    • Leafy Greens (Folate Boosters)

    Sukuma wiki, spinach, managu, and terere are rich in vitamins, minerals, and fiber that help repair DNA damage and lower inflammation. Lightly steam or fry with minimal oil. Avoid overcooking it.

    • Legumes and Soy

    Beans, lentils, and soy contain phytoestrogens, which may help slow the growth of cancer cells. These are excellent alternatives to red meat and are widely available and affordable.

    • Fish and White Meat

    Tilapia, omena, and chicken provide lean protein and omega-3 fatty acids that offer protection. It is advised that you grill or steam instead of frying.

    Food that increases the risk

    1. Red and Processed Meat

    This is a cultural favorite. When Kenyan food is mentioned, nyama choma is at the top of the list. Frequent consumption of nyama choma, sausages, and other processed meats introduces harmful compounds when cooked at high temperatures. We are not telling you to abandon it entirely, but moderation is Key.

    1. High-Fat Dairy

     High-fat milk is a daily staple. From morning tea to the evening ugali accompaniment, most Kenyans can’t fathom a life without it. However, research shows that full-cream dairy raises growth factors that fuel prostate cancer cells. A simple swap to low-fat milk or plant-based options offers the same comfort without the hidden danger.

    1. Excessive Alcohol

    Alcohol raises cancer risk and weakens the immune system — yet is a standard part of Kenyan social life. Limiting the alcohol to an occasional one drink or choosing a healthier alternative like fresh juice will keep the social life going without the long-term damage.

    Debunking Common Myths

    • Myth: “Only old men get prostate cancer.”
      Fact: Risk rises after 45, but lifestyle choices from a young age matter.
    • Myth: “If I feel fine, I don’t need screening.”
      Fact: Prostate cancer can be silent for years; only screening detects it early.
    • Myth: “Eating healthy is expensive.”
      Fact: Sukuma, beans, and tomatoes are among the most affordable foods in Kenyan markets.

    Next steps for Kenyan men

    If you are a Kenyan man over 45, or younger with a family history of prostate cancer, make screening a regular part of your health routine. Complement this with simple dietary changes: increase your intake of tomatoes, greens, beans, and fish, while reducing your consumption of red meat and alcohol. A balanced diet, alongside exercise, stress management, and regular screenings, creates a strong defense against prostate cancer. At NCI-K, we emphasize that early action saves lives; screening allows for detection when prostate cancer is most treatable. While nutrition cannot replace medical care, it serves as a controllable frontline defense starting with your next meal.

  • National Cancer Institute of Kenya Forges Global Partnerships at Harvard Summit

    National Cancer Institute of Kenya Forges Global Partnerships at Harvard Summit

    BOSTON, MA, 25th September, 2025 – The National Cancer Institute of Kenya (NCI-K) CEO, Dr. Elias Melly, participated in a three-day Global Health Catalyst Summit at Harvard University. Held from September 19 to 21, 2025, the summit provided a platform for international collaboration, bringing together top-notch minds from around the world to discuss innovations in global health and development. The event’s theme was “Catalyzing Win-Win Collaborations for Global Health and Development; Advancing Healthcare Outreach, Research, and Education Powered by AI.”

    Dr. Melly’s presentation focused on a crucial aspect of modern cancer treatment: a cross-disciplinary approach that explores the synergy between Clinical and Surgical Oncology. His talk highlighted Kenya’s commitment to adopting cutting-edge solutions in the fight against cancer.

    This event, organized by Harvard Zhu Family Center for Global Cancer Prevention and other partners drew together world Ministers, Institution Leaders, Industry, professionals from renown institutions and organizations including John Hopkins, University of Washington St Louis, Oxford University, International Atomic Energy Agency (IAEA), Union for International Cancer Control (UICC), AMSTRO, AAPM, AORTIC, Oncology Club, Leo Cancer Care USA, Diaspora and other C4 Stakeholders and many other renown institutions in the world.

    The National Cancer Institute of Kenya leadership is actively building international and regional collaborations and partnerships that will make the fight against cancer significantly easier. As a regional leader in cancer treatment and management, Kenya’s efforts are a beacon for East Africa. With leaders from Kenya, Uganda, and Tanzania coming together for the sole purpose of uniting their efforts, the establishment of the East Africa Cancer Institute is now closer than ever.

    A New Era of AI-Powered Cancer Care

    With the world technological advancements, featuring AI, health is a matter of concern, with the cancer diagnostics and treatments being at the centre of discussion, this is why one Key event milestone characterizing this summit is the historic implementation of the World’s first AI-powered comprehensive cancer centre in the cloud (C4) – delivering world class comprehensive care, outreach, research and education across the globe. This milestone achievement is a collaborative effort between Harvard Zhu Family Center for Global Cancer Prevention, MIT Computer Science and Artificial Intelligence Laboratory, The Religion and Global Health Forum at Garrett, University of Massachusetts Lowell Medical Physics & Radiological Science, and Johns Hopkins CaREER program.

    Presentations and discussions, from world-class professionals and experts, throughout the summit explored how AI can transform cancer care, with topics including:

    • Win-win Collaborative Radiotherapy Innovations powered by AI
    • Radiotherapy Reimagined: Can C4 and AI End the Cancer Divide by 2035?
    • C4 win-win Collaborative Radiotherapy Research
    • C4 Collaborative Radiotherapy Education
    • C4 for Comprehensive Care & Advocacy/Outreach
    • The Future of Cancer Prevention and Early Diagnostics
    • Implementing the 2025 World Health Organization Resolution on Strengthening Medical Imaging Capacity
    • C4 Cross-disciplinary Treatment: Clinical Oncology and Surgical Oncology
    • C4 for Research and Education

    A larger segment of time at this Summit was dedicated to showcasing innovations in cancer care, particularly those powered by technology. As discussed above, the presentations highlighted groundbreaking approaches, including how the C4 platform and AI can work together to end global cancer disparities by as early as 2035. Experts also explored how AI can optimize the coordination of multi-country clinical trials, including those for hypofractionated radiotherapy—a technique that can significantly increase patient access to treatment by reducing its duration. Additionally, sessions on cancer prevention and early detection underscored the importance of leveraging technology to improve public health outcomes.


    Beyond technology, the summit focused on strengthening global partnerships and improving healthcare development through a variety of initiatives. Discussions covered topics such as the ASCO-Global Oncology Implementation Science (GO-IS) initiative, which focuses on applying research to improve cancer care in low- and middle-income countries. The C4 Collaborations Platform was presented as a way to facilitate partnerships between institutions in the United States and low- and middle-income countries for a wide range of needs, including oncology and palliative care. Other vital topics included global health finance, the role of the diaspora in health exchange, and fostering diversity and inclusion in clinical trial partnerships.

    A Key takeaway from the summit was that the Global Health Catalyst Summit at Harvard presented a hub for world-class professionals and experts, where presentations and discussions explored a wide range of critical topics. These sessions were designed to catalyze international collaboration and leverage technology, particularly AI, to improve global health outcomes.

  • Kabarak University and International Cancer Institute Host a Landmark Conference on Advancing Cancer Care

    On September 18th and 19th, Kabarak University and the International Cancer Institute (ICI) co-hosted the 15th International Research Conference, drawing attention to Kenya’s urgent need for improved cancer care. The conference, themed “Advancing Access to Quality Cancer Care and Control,” brought together experts and stakeholders to discuss strategies for combating the rising incidence and mortality rates of cancer in the country.

    The event was officially opened by the Vice Chancellor of Kabarak University, Prof. Henry Kiplangat, PHD, MBS, OGW, who welcomed the distinguished attendees. He highlighted the grim cancer statistics from 2022, where 44,726 new cases and 29,317 deaths were reported in Kenya. In response to this crisis, Prof. Kiplangat announced the university’s Master of Pharmacy in Oncology Pharmacy program, the first of its kind in Kenya. Developed in collaboration with the ICI, the program is designed to produce specialized, “practice-ready” oncology pharmacists to meet national and global demand.

    The conference featured prominent speakers, including keynote speaker Dr. Mansoor Saleh, MD, Founding Chair of the Department of Hematology-Oncology at Aga Khan University and the guest speaker, Dr. Elias Melly, CEO of the National Cancer Institute of Kenya (NCI-K), who was represented by Ms. Emily Barsito, Head of Strategy, Planning, Partnerships, and Resource Mobilization, as she presented Dr Elias Melly’s speech.

    In his speech, the CEO stated that the conference was more than just a forum for dialogue; it symbolized a “joint commitment to preparing the next generation of professionals.” He identified Kabarak University and the ICI as “game-changers” in the cancer care ecosystem.He outlined three key areas of focus:

    • Training the Next Generation: Beyond pharmacy, he stressed the importance of equipping students in medical, nursing, and allied health fields for roles in prevention, diagnostics, and survivorship care.
    • Research and Innovation: He called for research to generate local data for targeted interventions, and to develop affordable diagnostics, natural product drugs, and cost-effective care models.
    • Collaboration with Government: He underscored the need for institutions to partner with the NCI-K to co-develop training programs and pilot new care models.

    Concluding his remarks, Dr Melly urged attendees to leave the conference with “action plans” and “partnerships,” and pledged the NCI-K’s unwavering support. “Let us create a Kenya and an Africa where quality cancer care is not the exception, but the norm. The time is now,” he stated, leaving a powerful call to action for everyone involved in the fight against cancer.

  • East Africa Unites in the Fight Against Cancer: Rays of Hope

    East Africa Unites in the Fight Against Cancer: Rays of Hope

    18th September, 2025 – Vienna, Austria – The heads of leading cancer institutes in East Africa have today joined forces to create the East Africa Cancer Institute Association (EACCIA). This agreement was made today at the 69th General Conference of the International Atomic Energy Agency (IAEA) in Vienna, initiating a new phase of regional collaboration in the fight against cancer.

    From left: Dr. Elias Melly, CEO National Cancer Institute of Kenya, Dr. Jackson Orem, Uganda Cancer Institute, and Dr. Diwani Misemo, Tanzania Ocean Road Cancer Institute

    From left: Dr. Elias Melly, CEO National Cancer Institute of Kenya, Dr. Jackson Orem, Uganda Cancer Institute, and Dr. Diwani Misemo, Tanzania Ocean Road Cancer Institute.

    The vision was born from the collective leadership of Dr. Elias Melly, CEO of the National Cancer Institute of Kenya; Dr. Jackson Orem, Director of the Uganda Cancer Institute; and Dr. Diwani Msemo of Tanzania’s Ocean Road Cancer Institute. As a show of unity, these leaders have laid the foundation for a unified front that will put together efforts in prevention, control, research, and treatment across the region. The EACCIA is set to be officially launched in Arusha in February 2026, a fitting location that symbolizes the spirit of the East African community and cooperation.

    The Power of Synergy and Regional Collaboration

    The importance of this association cannot be overstated. By working together, East African countries can overcome shared challenges, from limited resources and equipment to a shortage of trained specialists.

    • Knowledge and Data Sharing: A unified database and shared research platforms will allow for better understanding of cancer trends, risk factors, and effective interventions specific to the East African population. For example, cancers like esophageal cancer, which have a high age-standardized rate in Eastern Africa, can be addressed more effectively through collaborative studies.
    • Capacity Building: The EACCIA can facilitate joint training programs, exchange of medical professionals, and shared access to advanced medical equipment, ensuring that all member countries benefit from the latest advancements. This is critical for scaling up radiotherapy services, which are often in short supply, and for enhancing diagnostic capabilities.
    • Policy Harmonization: By speaking with a single voice, the association can more effectively advocate for regional health policies, secure funding from international partners, and influence global health agendas. This collective strength will be vital in creating robust and sustainable cancer control programs.

    This model of regional collaboration is a global best practice. From the European Society for Medical Oncology (ESMO) to the African Organisation for Research and Training in Cancer (AORTIC), history shows that working as neighbors creates a powerful force multiplier, accelerating progress and improving patient outcomes far more than any single country could achieve alone.


    Kenyan Delegation at the 69th IEAE General Conference in Vienna, led by Prof. Shaukat Abdulrazak

    The IAEA 69th General Conference: A Focus on “Rays of Hope”

    The IAEA’s 69th General Conference provided the perfect backdrop for this historic agreement, with the main theme being “Atoms of Water.” This theme showcased the diverse applications of nuclear science in areas like agriculture, climate, and water management. Under its “Rays of Hope” initiative, the IAEA is specifically committed to expanding access to cancer care in low- and middle-income countries by building capacity in diagnostic imaging, nuclear medicine, and radiotherapy. Kenya’s case was presented to the conference by Prof. Shaukat Abdulrazak, PhD, EGH, the Director for the Division for Africa at the IAEA Department of Technical Cooperation.

    The conference’s focus on leveraging nuclear science for health, food, and development provided a case on the need for international cooperation to address the world’s most pressing challenges. The newly formed East Africa Cancer Institutes Association (EACCIA) is a direct response to this global call to action, taking the “rays of hope” and transforming them into a tangible, coordinated effort for East Africa.

  • NCI-K and Lamu County Partner to Bring Cancer Services Closer to Home

    NCI-K and Lamu County Partner to Bring Cancer Services Closer to Home

    Lamu County – 17th September 2025 – The National Cancer Institute of Kenya (NCI-K) held a productive meeting with Lamu County Deputy Governor Dr. Mbarak Bahjaj at King Fahad Hospital. The primary focus of the discussion was to establish a robust collaboration between the County and NCI-K to address the region’s unique challenges in cancer care.

    ‎A major point of collaboration is NCI-K’s commitment to supporting the infrastructural development of a new cancer center within Lamu County. This initiative is a direct response to the significant geographical challenges faced by cancer patients in the Lamu islands, who must travel by boat and then by road to access treatment and care in Mombasa. This new center aims to bring essential services closer to the community.

    ‎In addition to this long-term project, the NCI-K team, led by Dr. Nashat Fadhloon Noor, Head of the Cancer Prevention and Control Directorate, is also participating in the ongoing Mawlid Celebration. As part of this festival, which commemorates the birth of Prophet Mohammed, NCI-K is providing free cancer screening, education and awareness programs to the community.

    ‎The National Cancer Institute of Kenya remains committed to its mission of reaching all marginalized regions to provide cancer education, awareness, and screening services, living to its vision “Towards a Cancer Free Nation” ensuring that no one is left behind in the fight against cancer.

    0#
  • Silence and Stigma

    Silence and Stigma

    Every September, the world comes together to shine a light on four cancers — Blood, Childhood, Gynaecological, and Prostate. In Kenya, awareness has grown, yet silence and stigma still hold many back from seeking timely testing and diagnosis when it matters most. Each year, thousands of lives are lost not only to cancer itself but also to the quiet fear that surrounds it. Recent statistics paint a sobering picture: about 45,000 new cases and 29,000 deaths annually. Behind these numbers lies a deeper truth — too many Kenyans are diagnosed late, not because hospitals cannot help, but silence, fear, and stigma delay the very first step to care. Why many wait until it is too late is a question whose answer only lies in homes and communities.

    Kenya has not been silent on paper. The Kenya Cancer Care Policy 2019–2030 calls for greater awareness, prevention, early detection, and improved caregiving. The Mental Health Policy also warns that stigma is a stumbling block to timely diagnosis, one that deepens the stress for patients and their families. Our CEO, Dr. Elias Melly, reminds us that policies only come alive when they reach people. “We will win in the community, not in the clinics. Investing one dollar in prevention saves sixteen in treatment.” He further emphasized that, as the country moves towards primary care, there is an urgent need to train healthcare workers and community health promoters to recognize symptoms early.

    Yet policies and plans only tell part of the story. Behind every statistic is a human face, and it is often survivors who remind us what silence and stigma really cost. At the 2nd  National Cancer Summit, childhood cancer survivor Robert recalled: “I was only six when I was diagnosed. There were no pediatric wards and no one to explain what was going on. The pain wasn’t just physical; it was emotional. An invisible scar I still carry to date.” Other survivors at the forum echoed the same pain, with one saying: “The hardest part was not the treatment — it was the silence. People avoided me. They whispered instead of asking how I was.”

    Cancer is not always a death sentence, but silence can be. Breaking stigma begins with open conversations- in families, workplaces, churches, and communities. Speaking up encourages early screening, offering support restores dignity, and challenging myths saves lives. As we mark this September of awareness, let us remember: silence and stigma are battles we can all fight, and by doing so, we give more Kenyans the chance not just to survive, but to live fully.

  • New Cancer Centre for Kisumu: A Bold Step Forward

    A significant meeting took place on September 5, 2025, at the Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH) in Kisumu, bringing together key stakeholders to discuss a potential game-changing initiative: the establishment of a Comprehensive Cancer Centre (CCC). This new center, a proposed partnership between the Korean government and Kisumu County, aims to address a critical healthcare gap in the region.

    The meeting highlighted the urgent need for a dedicated cancer facility. Kisumu’s First Lady, H.E. Dorothy Nyong’o, pointed out that a staggering 80% of cancer patients in the county are currently referred elsewhere for treatment. This not only burdens families with high costs but also delays and compromises care. A local, comprehensive center would drastically change this, making life-saving services accessible to the lakeside region.

    Support for the project was strong and unanimous. The National Cancer Institute of Kenya (NCI-K), represented by Mr Joel Owino, and Mr. Elijah Omondi, reaffirmed its commitment to ensuring the center meets national standards and contributes vital data to the National Cancer Registry. The Kisumu County Health Department and the leadership of JOOTRH both endorsed the plan, seeing the standalone centre as a crucial expansion of the region’s healthcare capacity. Ms. Wairimu Mwaura from the Africa Cancer Foundation also backed the idea, noting that a consolidated centre would streamline care and improve patient experience.

    The most insightful remarks came from Dr. George Rae, the former CEO of JOOTRH, who shared valuable lessons from past attempts to establish a cancer center. He spoke of previous negotiations with various international partners and the challenges that stalled those efforts. Dr. Rae stressed the importance of learning from the past to ensure the new Korean partnership is built on a foundation of strong governance and long-term sustainability.

    This project represents a hopeful new chapter for cancer care in Kisumu. By leveraging international collaboration and building on the wisdom of past experiences, the new Comprehensive Cancer Centre has the potential to transform healthcare for thousands of people, bringing quality, affordable treatment closer to home.

  • Reviewing National Cancer Treatment Guidelines to Enhance Quality Cancer Care

    From 3rd to 5th September 2025, the National Cancer Institute of Kenya (NCI-K), in partnership with the Ministry of Health, convened a three-day National Cancer Treatment Guidelines Review Workshop at Sarova Hotel, Nairobi. The event marked a significant milestone in Kenya’s ongoing efforts to strengthen cancer care and improve patient outcomes.

    The workshop brought together a multidisciplinary team of experts, including oncologists, oncology nurses, pharmacists, and pathologists, alongside representatives from leading health facilities such as Moi Teaching and Referral Hospital (MTRH), Kenyatta University Teaching, Referral & Research Hospital (KUTRRH), and Kenyatta National Hospital (KNH). County representatives from Meru, Nyeri, Nakuru, Mombasa, Garissa, Machakos, Makueni, Kitui, Kakamega, and Kisumu also participated, reflecting a nationally inclusive approach to improving cancer care delivery.

    Graced by the CEO of NCI-K Dr. Elias Melly and the Director-General of the Ministry of Health Dr. Patrick Amoth, the workshop focused on reviewing and updating the 2019 National Cancer Treatment Guidelines and the Adult & Childhood Cancer Differentiated Care Packages (2022/23). With GLOBOCAN 2022 estimating 44,726 new cancer cases and 29,317 related deaths annually in Kenya, the review aimed to integrate emerging diagnostic tools, innovative treatment modalities, paediatric cancer protocols, and updated costing structures to make cancer care more accessible, effective, and aligned with Universal Health Coverage (UHC).

    In his remarks, Dr Melly applauded the practitioners for their dedication and excellent work in advancing cancer care across the country. He reaffirmed NCI-K’s commitment to ensuring the successful implementation of the updated guidelines and emphasized the importance of continued collaboration among healthcare professionals, institutions, and stakeholders. 

    Key outcomes from the workshop included evaluating the effectiveness of the existing guidelines, incorporating latest scientific research and treatment technologies, and developing an implementation framework to ensure the smooth dissemination and adoption of the updated guidelines nationwide. The inclusive participation of counties and major referral hospitals underscored the importance of collaboration and collective action in addressing Kenya’s cancer burden.

    Once finalized and validated, the updated guidelines will be disseminated to healthcare providers across the country to standardize cancer care, improve treatment outcomes, and enhance equitable access to quality cancer services. This milestone reflects Kenya’s continued commitment to evidence-based, patient-centred, and sustainable cancer care.

  • Strengthening HPV DNA Testing: A Unified Push Against Cervical Cancer in Kenya

    In a landmark two-day workshop hosted at the Argyle Grand Hotel, key public and private sector stakeholders united to chart a stronger pathway for the uptake of HPV DNA testing in Kenya. The convening responded to the country’s persistently low cervical cancer screening coverage and the even lower uptake of HPV DNA testing, despite its proven effectiveness in early detection of high-risk infections

    The meeting brought together a diverse coalition of actors including the National Cancer Institute of Kenya (NCI-K), Ministry of Health, Ministry of Defence, county governments, Roche, Clinton Health Access Initiative (CHAI), CIHEB, Old Mutual, and county-level laboratory and health officials.

    The central theme was the urgent need to reverse Kenya’s high cervical cancer mortality by shifting to evidence-based strategies. Participants emphasized that HPV DNA testing offers superior sensitivity compared to older methods such as VIA or Pap smears, making it a cornerstone in the fight against cervical cancer.

    A high-level panel featuring Dr. Elias Melly (CEO, NCI-K), Dr. Taofik Oloruko Oba (Roche), Lance Osiro (CHAI), Pamela Were, and Sylvia Kadima underscored the importance of multi-sectoral collaboration. Deliberations highlighted distinct roles: government in creating policy and financing frameworks, NGOs and development partners in community mobilization, and the private sector in scaling access to innovative diagnostics and sustainable financing solutions.

    Practical sessions formed a key part of the workshop. Breakout groups, led by Dr. Michelle Nguu, Pamela Were, and Faith Mathai, tackled ground-level implementation. Participants engaged in:

    Hands-on demonstrations of sample collection techniques, with emphasis on self-sampling methods to increase women’s comfort, privacy, and uptake.

    Practical laboratory exercises, covering HPV DNA processing workflows, quality assurance protocols, and approaches for improving turnaround time of results.

    Simulation of referral and follow-up pathways, ensuring women who test positive are seamlessly linked to diagnosis and treatment services.

    Exploration of implementation models, ranging from county-level integration into existing RMNCAH platforms to employer-based wellness programs, including Old Mutual’s workplace health initiatives.

    The workshop closed with a plenary session where county teams and partners presented recommendations. There was strong consensus on the need for sustained national coordination, resource pooling, and community-centered strategies to normalize HPV testing.

    The collective commitment was clear: through strategic partnerships and practical implementation, Kenya can transform cervical cancer from a leading killer into a preventable and treatable disease for all women.

  • Global Spotlight: NCI-K’s CEO Featured in New York Capital Times

    Kenya’s leadership in the fight against cancer has been recognized on a global scale. A recent article in The New York Capital Times, featuring our CEO, Dr. Elias Melly, highlights how his vision is advancing the future of cancer care in Kenya and serving as a global benchmark.

    The feature titled “The future of cancer care is being written by Elias Melly” reflects on Dr. Melly’s journey from the international Halls of Academia to grassroots healthcare in Kenya. Educated in leading Institutions abroad, he chose to return home and is determined to ensure that cancer care is accessible to all and not a privilege of a select few.

    Under Dr. Melly’s leadership, NCI-K now boasts of decentralized cancer centers from Nairobi to counties- equipping regional hubs, enhancing screening services, and ensuring no family faces financial ruin in the quest to treat cancer. This shift has brought dignity, hope, and care closer to communities. Understanding the importance of homegrown solutions, Dr. Melly pioneered the creation of Kenya’s first comprehensive cancer database.

    This step ensured that policies are formulated based on our realities and not borrowed assumptions. It has also advanced affordable care packages through SHA.Beyond equipment and data, Dr. Melly invests in people. He lectures future oncologists and continues to nurture expertise and a culture of compassion in cancer care.

    His commitment extends to supporting local researchers and fostering international collaborations that enhance Kenya’s voice in global health issues. The article also expresses Dr. Melly’s ambition in positioning Kenya as a continental hub for cancer innovation. With the recent success of the 2nd National Cancer Summit, NCI-K is now preparing to host the Global Cancer Summit in 2027, which will bring together thought leaders, health practitioners, and advocates from across the world.

    While this recognition shines a light on Dr. Melly, it is a win for everyone who believes in the steps of achieving a healthier Kenya, from families, patients, to healthcare practitioners. At NCI-K, we are proud of this global recognition and are committed to ensuring that early detection, accessible treatment, and hope for recovery reach every Kenyan.